Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34089023

about

Transarterial radioembolization for hepatocellular carcinoma: a review Current status of transarterial radioembolization New advances in hepatocellular carcinoma Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments Interventional therapies for hepatocellular carcinoma Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives Selective Internal Radiation Therapy (SIRT) as Conversion Therapy for Unresectable Primary Liver Malignancies Update in management of hepatocellular carcinoma in Eastern population Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.Current management of hepatocellular carcinoma.A multidisciplinary approach to the management of hepatocellular carcinoma.Radiation therapy for liver tumors: ready for inclusion in guidelines?Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection.Updates in the management of hepatocellular carcinoma Transarterial therapies for hepatocellular carcinoma.Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011 Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.Radioembolization for primary and metastatic liver cancer.Intermediate hepatocellular carcinoma: How to choose the best treatment modality?Hong Kong consensus recommendations on the management of hepatocellular carcinoma.Yttrium-90 microsphere radioembolization for hepatocellular carcinoma.Interventional radiological treatment of hepatocellular carcinoma: an update.Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.Transcatheter intraarterial therapies: rationale and overview Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial Clinical guideline SEOM: hepatocellular carcinoma Dramatic Response of a Large, 10 Cm Hepatocellular Carcinoma to Monotherapy with Yttrium-90 Based Selective Internal Radiation Therapy.Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma.Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials.Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib

P2860

Q26738273-10A351C9-4431-4907-AB4F-C18B29CE4B00 Q26744307-B1FF6858-611A-4E31-85AA-C1D97CFBAD8D Q26749329-E14E09D6-CF5F-4390-AD7B-CD5E8D282787 Q26753089-7C39A3B2-CDC1-423C-B607-CDD7A1CE89BC Q26851627-A2B6A4F6-AA7B-43D8-A962-C1A59D4882A9 Q26852174-62E5EC9F-DF86-48FE-9532-8D8ACDA5DCB1 Q26864803-2F55848D-5283-49E7-BFAB-E5D89A5DE871 Q27023616-31270811-26D3-46CA-9E0E-6A2EA8EF4F87 Q28071594-57262671-C6F9-4984-9CC3-7888D502927D Q28080480-5B5C615B-B6C2-47B3-817D-647F161940E2 Q28081783-F32FAE16-50EB-40A5-BE95-AF3FE7C30C2D Q28314897-2A5D2E07-E27B-4417-BDA8-704D2C1D4C50 Q30248206-E5865C77-8A84-40B7-8D2F-81E8DDA68D4D Q33582165-81AD8C9A-5AD2-426E-8B16-0AFA7AAA8FB1 Q33916361-CE6CA3C3-C46B-4AD4-85AA-C60971F0565E Q34005194-9545257A-BCE3-4B9E-8942-9FC57AE6DA7E Q34077181-830C7023-C2CE-49DB-83E4-F61D9131FFB3 Q34571160-74C5ED83-0163-411E-B307-E5DE8A6EF548 Q34628257-E754D76B-A035-46CA-BC64-BAC9D8CBB731 Q34702094-BB9AC139-654E-4072-872F-C5B9D852BA8D Q35085486-8D83A0A3-D32A-4426-ABC7-AF832AEB9D1F Q35096101-C7C3CDB0-B572-4795-BD0B-888D638B8BB9 Q35506937-8B33A500-6749-44FC-AF82-031947FCFA43 Q35564038-0B396BD3-A831-49D8-BBD2-81130D007A1C Q35626764-5487C7FA-EF51-4F9B-B0C8-974986A1D969 Q35631295-A69E01C6-166C-45FA-A5C3-86B401D33276 Q35631304-DD1397A7-626B-4B36-BFEE-A11F4610A711 Q35675131-184EF7D1-4951-4300-8B61-E08D90EB47A4 Q35715947-6EE1C72B-938B-4DDC-9162-6B869DC193C9 Q36062588-09DF9ED8-9C3E-4836-A551-673E1C306349 Q36104314-40FED7CF-6DC9-4A10-A622-372E016AA437 Q36383875-B92E4B3F-C0DD-4BE4-A284-3A003F324B66 Q36400259-8435F67A-5F8D-45E0-B9B9-63495608F4FA Q36505147-B828972F-5800-4AC2-A516-C46F72C43D67 Q36673829-D7DCD34C-F2B7-40D4-B5AC-C986627B8191 Q36865115-A09C87E7-1A66-4BFC-B66D-57FC054A7493 Q36886453-87469BC0-B367-462C-942D-6D9D7A8FF365 Q36936990-6FB8AF53-DDFC-4E2F-AF93-79335B02E6AC Q37124697-11315DFC-AA59-491B-B02C-9DDCBEE003C3 Q37417900-52436278-51AB-463E-A09A-B008917D8522

P2860

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34089023

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.

@ast

Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.

@en

Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.

@nl

type

label

Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.

@ast

Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.

@en

Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.

@nl

prefLabel

Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.

@ast

Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.

@en

Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.

@nl

P1433

Q34089023-F4D89872-7126-4553-9556-F932ED9DD582

P1476

Q34089023-23A81521-8021-4B7A-A971-29A8BB9CF92A

P2093

Q34089023-07847013-2EE7-4A1B-8748-61CB752C2ECF

Q34089023-2D9FF7F5-7F1D-4BE0-BE4C-1EDFE0A5E28D

Q34089023-3914EC6B-D7F4-4E4C-98FA-0E21049B33AD

Q34089023-79234170-7BCF-47FF-9FDF-F563E05958D5

Q34089023-7E8A0978-180A-49AB-AD87-CD3DF0DE5A4C

Q34089023-901B950F-11B7-4005-B43A-1228FB150F54

Q34089023-DE7A810C-6026-4E7D-9D8B-D062347137A1

Q34089023-FEE1CE0E-7057-4578-8D03-785BFD33CEA1

P304

Q34089023-4B654CDE-5906-4C30-B3A3-4675263EEC19

P31

Q34089023-6331ECA4-4355-42E5-973B-54588787AF78

P356

Q34089023-D11F3B67-D20F-4318-86E5-B54B36B4AA96

P433

Q34089023-7ED88AC4-C645-4819-B6E0-AE2D0067D9CB

P478

Q34089023-E9EAA40D-B8C8-49F2-B868-9E277C209609

P577

Q34089023-2A2C9246-E38D-4258-8FAD-95455D25ED56

P5875

Q34089023-941E2185-BB3E-4766-8A79-BD5E03570607

P698

Q34089023-C3DBC4AA-E2BD-4AD5-9777-AB34BAED324F

P356

J.JVIR.2009.10.013

P1433

Journal of Vascular and Interventional Radiology

P1476

Comparison of yttrium-90 radio ...... able hepatocellular carcinoma.

@en

P2093

Abbas Chamsuddin

http://www.w3.org/2001/XMLSchema#string

Charles A Staley

http://www.w3.org/2001/XMLSchema#string

David A Kooby

http://www.w3.org/2001/XMLSchema#string

Hyun S Kim

http://www.w3.org/2001/XMLSchema#string

John Kauh

http://www.w3.org/2001/XMLSchema#string

Keith A Delman

http://www.w3.org/2001/XMLSchema#string

Swetha Srinivasan

http://www.w3.org/2001/XMLSchema#string

Vasili Egnatashvili

http://www.w3.org/2001/XMLSchema#string

P304

224-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JVIR.2009.10.013

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40730265

http://www.w3.org/2001/XMLSchema#string

P698

20022765

http://www.w3.org/2001/XMLSchema#string